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Abstract: An efficient synthesis of a series of 4′-oxyalkyl-isocordoin analogues (2–8) is reported
for the first time. Their structures were confirmed by 1H-NMR, 13C-NMR, and HRMS.
Their anti-oomycete activity was evaluated by mycelium and spores inhibition assay against two
selected pathogenic oomycetes strains: Saprolegnia parasitica and Saprolegnia australis. The entire
series of isocordoin derivatives (except compound 7) showed high inhibitory activity against these
oomycete strains. Among them, compound 2 exhibited strong activity, with minimum inhibitory
concentration (MIC) and minimum oomyceticidal concentration (MOC) values of 50 µg/mL and
75 µg/mL, respectively. The results showed that 4′-oxyalkylated analogues of isocordoin could
be potential anti-oomycete agents.
Keywords: isocordoin; oxyalkyl derivates; anti-oomycete activity; Saprolegnia sp.
1. Introduction
Chalcones bearing prenyl groups are an abundant subclass of naturally occurring chalcones [1].
The biosynthesis of C-prenyl chalcones involves the coupling of products from the shikimic and
mevalonic acid pathways. The latter produces the prenyl group, while the former produces
the aromatic compound. The two products are linked together by prenyl tranferase enzymes [2].
Almost 80% of these molecules are monoprenylated and the remaining 20% consist of di and/or
triprenyl derivatives. C-prenylation takes place more frequently on ring A at positions 3′ and/or
5′, as well as 3 and/or 5 [3]. Prenylated chalcones have been isolated from plants mainly
belonging to the families of Leguminosae and Moraceae [4]. This class of compounds has
been found to display a variety of biological activities that are anticarcinogenic, antiprotozoal,
larvicidal, anti-inflammatory, antibacterial, antioxidant, and antifungal [5,6]. A representative
example of naturally occurring bioactive C-prenylated chalcones, isocordoin (1), was isolated
from Lonchocarpus species [7,8] or Aeschynomene fascicularis [9]. Isocordoin has been found to
have a range of interesting biological properties in vitro that may have therapeutic and industrial
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utilities including antiprotozoal (for treatment of Leishmania mexicana, L. braziliensis, L. amazonensis
and Trypanosoma cruzi) [10,11], insect antifeedant (for treating lepidopterous larvae of Spodoptera
littoralis and S. exempta, which are considered one of the most destructive pests of crops) [12] and
a vasorelaxant effect [13], as well as a potential “broad-spectrum” anticancer agent (applicable to
both oral-laryngeal and prostate cancers) [9,10,14]. These bioactivities have stimulated the interest
of researchers in the preparation of isocordoin. The synthesis of 1 via the Claisen–Schmidt
condensation was obtained in unsatisfactory yields [15,16]. In contrast, the enzymatic prenylation of
2′,4′-dihydroxychalcone with cell cultures of Morus nigra biosynthetically produced isocordoin in very
high yield [16,17]. Recent works have explored the introduction of isoprenoids into the structure of
chalcones to obtain more active hybrid compounds [18], or even with new biological properties for
the development of novel products either in medicine or in agrochemistry. In this paper, a series of
4-oxyalkyl-isocordoin analogues 2–8 were synthesized and evaluated for their anti-oomycete activity
against Saprolegnia parasitica and S. australis.
2. Results and Discussion
2.1. Synthesis and Characterization
One naturally occurring chalcone, 1, and seven oxyalkyl derivates, 2–8, were synthesized.
The synthetic strategies applied for the synthesis of new chalcones are outlined in Scheme 1 [19,20].
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Scheme 1. Synthesis of 4-oxyalkyl-isocordoin derivatives 2–8. Reagents and conditions: (i) 
K2CO3/CH3CN, reflux at 80 °C for 4 h.; (A) CH3I; (B) allyl bromide; (C) 2-methyl-1-propenyl bromide; 
(D) crotyl bromide; (E) prenyl bromide; (F) geranyl bromide; (G) farnesyl bromide.  
Isocordoin (1) was purified in analogy to the procedures described in [21,22] with small 
variations from the resinous exudate of Adesmia balsamica. The targeted compounds 2–8 were easily 
attained in high yields (70–92%) through nucleophilic substitution of isocordoin with the 
Scheme 1. Synthesis of 4-oxyalkyl-isocordoin derivatives 2–8. Reagents and conditions:
(i) K2CO3/CH3CN, reflux at 80 ◦C for 4 h.; (A) CH3I; (B) allyl bromide; (C) 2-methyl-1-propenyl
bromide; (D) crotyl bromide; (E) prenyl bromide; (F) geranyl bromide; (G) farnesyl bromide.
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Isocordoin (1) was purified in analogy to the procedures described in [21,22] with small variations
from the resinous exudate of Adesmia balsamica. The targeted compounds 2–8 were easily attained
in high yields (70–92%) through nucleophilic substitution of isocordoin with the appropriate alkyl
halide in acetonitrile. This reaction resulted in the exclusive formation of the 4-oxyalkyl-derivative,
due to steric hindrance caused by the the prenyl chain in position 3′ of the aromatic ring A [23,24] and
the influence exerted by the intramolecular hydrogen bond present in the isocordoin [25].
The structures of compounds 1–8 were established on the basis of IR, NMR, and HR-MS
techniques. 13C-NMR assignments were achieved by 2D heteronuclear single quantum correlation
(HSQC) and heteronuclear multiple bond correlation (HMBC) experiments.
The IR, NMR, and MS data of compound 1 concurred with those reported for the known
chalcone, commonly named as isocordoin, previously reported from Lonchocarpus xuul [8].
The 1H spectrum of 4′-oxyalkyl-isocordoin derivatives 2–8 showed a number of signals that correspond
to an isocordoin-type structure. The spectra of these compounds showed two trans-olefinic protons at
δ = 7.89 and 7.60 ppm (d, J = 15.4 Hz) readily assigned to those of the 8 and 7 position, respectively;
two aromatic protons at ortho positions (d, J = 9.1 Hz at δ = 6.48 and 7.77 ppm); and the presence
of a prenyl group (d, J = 7.1 Hz, 2H at δ = 3.39–3.40 ppm; m, 1H at δ = 5.25 ppm; and two
singlets, 3H each, at δ = 1.68 and 1.80 ppm), and two multiplets at δ = 7.65 ppm (2H) and 7.42 ppm
(3H), corresponding to the five protons of a unsubstituted aromatic ring. The 1H-NMR spectrum
of 2–8 showed a chelated hydroxyl-proton signal at δ 13.39–13.37 ppm, together with a chelated
carbonyl-carbon resonance at δ = 192.1 ppm, were consistent with the selectivity of the O-alkylation at
position 4′ of isocordoin. The compound 2, obtained as an amorphous bright yellow solid, proved to
be identical to derricin, previously reported from Lonchocarpus sericeus [26]. For 4′-oxyalkyl-isocordoin
derivatives 3–8 the 1H-NMR spectrum revealed resonances at δ = 4.54–4.65 ppm (d, 2H) ascribed to
O-CH2 protons of alkoxy chain linking 4′-OH-chalcone ring. This is characteristic of allylic chains
on aromatic rings, resulting by the alkylation reaction. For example, the 1H-NMR spectrum of
compound 3 showed the signal at 4.65 ppm (d, J = 5.1 Hz, 2H, H-1′ ′) correlated (by 2D HSQC) with
a carbon atom at δ 65.4 ppm (C-1”), indicating the coupling point between the allyl fragment and
the aromatic hydroxyl group. These data also were corroborated by 2D HMBC correlations, where H-1”
showed heteronuclear 3J correlations with the carbons signal at δ = 117.6 (C-3′ ′) and 162.6 (C-4′) ppm.
Heteronuclear 2J correlations were also observed at δ 132.7 (C-2”) (Figure 1).
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Figure 1. The most important correlations shown by 2D 1H-13C HMBC, compound 3.
2.2. Anti-Oomycete Activity Assays of Compounds 1–8
In this study, isocordoin (1) and a series of seven oxyalkylated derivatives (2–8) were screened for
minimum inhibitory concentration (MIC) values (Table 1).
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Table 1. The MIC values a of the compounds 1–8 against Saprolegnia species.
Compounds
MIC (µg/mL)
S. parasitica S. australis
1 >200 200
2 75 50
3 100 75
4 125 125
5 100 75
6 150 125
7 >200 >200
8 150 75
Bronopol >200 175
Clotrimazole 125 150
Itraconazole 100 100
a Each value represents the mean ± SD of three experiments (p < 0.05), performed in quadruplicate.
Among them, isocordoin (1) and compound 7 were considered to have no inhibition effect against
Saprolegnia with MIC values ≥ 200.0 µg/mL, while the other six compounds showed anti-oomycete
activities with MIC ≤ 150.0 µg/mL, in which derricin (2) and compound 3 had the most promising
anti-Saprolegnia activities with MIC values of 50 and 75 µg/mL, respectively.
Table 2 lists the minimum oomyceticidal concentration (MOC) values of compounds 1–8 against
Saprolegnia spores at 72 h. The results reveal that derricin (2) showed significant anti-oomycete activity
with an MOC value of 75 µg/mL, followed by compound 3 with a value of 100 µg/mL.
Table 2. The MOC values a of the compounds 1–8 against spores at 72 h.
Compounds
MOC (µg/mL)
S. parasitica S. australis
1 >200 >200
2 75 75
3 100 100
4 125 125
5 125 100
6 150 150
7 >200 >200
8 150 100
Bronopol >200 200
Clotrimazole 150 175
Itraconazole 100 100
a Each value represents the mean ± SD of three experiments, performed in quadruplicate.
Table 3 lists the mycelial growth inhibition (MIG) percentage values of compounds 1–8 against
Saprolegnia mycelium at 48 h.
The growth inhibition rate of Saprolegnia after 48 h of exposure to derricin (2) to was partially
affected by the concentration of the chemical. However, it was more than twice as effective as bronopol,
a broad-spectrum biocide, that has been used as an effective and economically acceptable alternative in
the treatment and control of Saprolegnia sp. [20]. The inhibition of S. parasitica and S. australis was 52%
and 58%, respectively, with concentrations of derricin at 200 µg/mL.
The results of this research provides evidence that lipophilicity is an important characteristic of
anti-oomycete agents, such as ketoconazole and clotrimazole [27–30], and it is also evident that drugs
with oxyalkyl chains on the A-ring contribute to an increase in anti-oomycete activity [20,31], which
has proven effectiveness in the treatment of Saprolegniasis.
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Table 3. The MIG values of the compounds 1–8 against mycelium at 48 h.
Compounds (200 µg/mL)
MIG (%)
S. parasitica S. australis
1 0 0
2 52 58
3 38 42
4 35 38
5 25 30
6 28 30
7 0 0
8 31 33
Bronopol 0 33
3. Materials and Methods
3.1. General
All chemicals were obtained from Aldrich (St. Louis, MO, USA) and were used without
further purification. A detailed description of conditions used to register Fourier transform infrared
(FT-IR) spectra, high resolution mass spectra, and 1H, 13C, 13C DEPT-135, gs-2D Heteronuclear
Single Quantum Coherence (HSQC) and gs-2D HMBC spectra has been given elsewhere [32].
Column chromatography (CC) was performed with silica gel 60 from Merck (Darmstadt, Germany),
and thin layer chromatography (TLC) was carried out on precoated silica plates F-254 from Merck
(Darmstadt, Germany). Melting points were determined on an electrothermal instrument and
are uncorrected.
3.2. Plant Material
Adesmia balsamica were collected in Melosillas, Casablanca, Chile, in October 2016. A voucher
specimen was deposited at the Valparaíso (VALP) Herbarium, Department of Biology, Universidad
de Playa Ancha, Valparaíso, Chile and was identified by comparison with the herbarium specimen
(collection number 1899).
3.3. Isolation and Characterization of Isocordoin (1)
The fresh plant (1.0 kg) extracted with cold dichloromethane (5 L) at room temperature for 40 s.
The organic extract was concentrated in a rotatory evaporator to give a residue of 120.5 g of resin. Pure
isocordoin (1) was isolated to obtain 166.5 mg of a solid yellow powder. Its structure was established by
comparison of their spectroscopic data (1H and 13C-NMR and HRMS) with those in the literature [8].
3.4. General Procedure for the Synthesis of 4-Oxyalkyl-isocordoin Analogues (2–8)
A solution of isocordoin (1) (5 mmol), alkyl halide (6 mmol), and K2CO3 (6.5 mmol) in anhydrous
acetonitrile (3 mL) was refluxed for 4 h at 80 ◦C. After the reaction, the mixture was distilled to remove
the solvent. The residue was poured into ice water (40 mL), and then filtered. The resulting filtrate
was extracted three times with ethylacetate. The resulting organic phase was dried over anhydrous
magnesium sulfate, and distilled in vacuo to remove the solvent to provide the target compounds 2–8.
(2E)-1-[2-Hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (2). Yellow solid.
Yield: 89.0%. Spectroscopic data and physical properties of compound 2 were consistent with those
reported in the literature [26].
(2E)-1-[4-(Allyloxy)-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (3). Yellow solid.
Yield: 92.0%, melting point: 93–96 ◦C. IR (KBr, cm−1): 3024, 2895, 1647, 1577, 1298, 1195, and 1134.
1H-NMR (400 MHz, CDCl3): δ 13.37 (s, 1H, 2′-OH), 7.88 (d, J = 15.4 Hz, 1H, H-8); 7.77 (d, J = 9.1 Hz,
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1H, H-6′); 7.65 (m, 2H, H-2 and H-6); 7.60 (d, J = 15.4 Hz, 1H, H-7); 7.42 (m, 3H, H-3, H-4 and
H-5); 6.48 (d, J = 9.0 Hz, 1H, H-5′); 6.07 (m, 1H, H-2′ ′); 5.45 (m, 1H, H-3′ ′b); 5.31 (m, 1H, H-3′ ′a);
5.26 (m, 1H, H-8′); 4.65 (d, J = 5.1 Hz, 2H, H-1′ ′); 3.40 (d, J = 7,1 Hz, 1H, H-7′); 1.80 (s, 3H, H-10′);
1.68 (s, 3H, H-11′). 13C-NMR (100 MHz, CDCl3): δ 192.4 (C-9); 163.2 (C-2′); 162.4 (C-4′); 144.1 (C-7);
134.8 (C-1); 132.7 (C-2′ ′); 131.8 (C-6′); 130.5 (C-9′); 129.1 (C-4); 129.0 (C-2 y C-6); 128.5 (C-3 y C-5);
121.9 (C-8′); 120.6 (C-8); 118.4 (C-3′); 117.6 (C-3′ ′); 114.6 (C-1′); 103.2 (C-5′); 65.4 (C-1′ ′); 25.8 (C-11′);
21.8 (C-7′); 17.9 (C-10′). MS: M + H ion m/z 349.4432 (C23H24O3: 348.4348).
(2E)-1-[4-[(2-Methylprop-2-en-1-yl)oxy]-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (4).
Yellow solid. Yield: 85.0%, melting point: 99–101 ◦C. IR (KBr, cm−1): 2958, 1635, 1519, 1243, and 1131.
1H-NMR (400 MHz, CDCl3): δ 13.39 (s, 1H, 2′-OH), 7.87(d, J = 15.5 Hz, 1H, H-8); 7.77 (d, J = 9.0 Hz, 1H,
H-6′); 7.65 (m, 2H, H-2 and H-6); 7.60 (d, J = 15.4 Hz, 1H, H-7); 7.42 (m, 3H, H-3, H-4 and H-5); 6.48 (d,
J = 9.0 Hz, 1H, H-5′); 5.26 (m, 1H, H-2′ ′); 5.11 (s, 1H, H-3b′ ′); 5.01 (s, 1H, H-3a′ ′); 4.54 (s, 2H, H-1′ ′);
3.43 (d, J = 7.1Hz, 1H, H-7′); 1.84 (s, 3H, H-4′ ′); 1.80 (s, 3H, H-10′); 1.68 (s, 3H, H-11′). 13C-NMR (100
MHz, CDCl3 ): δ 192.2 (C-9); 163.2 (C-2′); 162.4 (C-4′); 144.1 (C-7); 140.3 (C-2′ ′); 134.9(C-1); 131.8 (C-6′);
130.5 (C-9′); 129.1 (C-4); 129.0 (C-2 and C-6); 128.5 (C-3 and C-5); 122.0 (C-8′); 120.6 (C-8); 117.8 (C-3′);
114.6 (C-1′); 113.0 (C-3′ ′); 103.2 (C-5′); 71.9 (C-1′ ′); 25.8 (C-11′); 21.8 (C-7′); 19.3 (C-4′ ′); 17.9 (C-10′).
MS: M + H ion m/z 363.4702 (C24 H26O3: 362.4616).
(2E)-1-[4-(Crotyloxy)-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (5). Yellow solid.
Yield: 85.0%, melting point: 93–94 ◦C. IR (KBr, cm−1): 2958, 1635, 1519, 1243, and 1131. 1H-NMR (400
MHz, CDCl3): δ 13.37 (s, 1H, 2′-OH), 7.87 (d, J = 15.5 Hz, 1H, H-8); 7.77 (d, J = 9.1 Hz, 1H, H-6′); 7.65 (m,
2H, H-2 and H-6); 7.60 (d, J = 15.4 Hz, 1H, H-7); 7.42 (m, 3H, H-3, H-4 and H-5); 6.49 (d, J = 9,0 Hz,
1H, H-5′); 5.87 (m, 1H, H-2′ ′); 5.82 (m, 1H, H-3′ ′); 5.26 (m, 1H, H-8′); 4.57 (d, J = 5.9 Hz, 2H, H-1′ ′);
3.40 (d, J = 7.2 Hz, 1H, H-7′); 1.80 (s, 3H, H-10′); 1.77 (s, 3H, H-4′ ′); 1.68 (s, 3H, H-11′). 13C-NMR (100
MHz, CDCl3): δ 192.2 (C-9); 163.2 (C-2′); 162.6 (C-4′); 144.0 (C-7); 134.9 (C-1); 131.7 (C-6′); 130.5 (C-9′);
130.3 (C-4); 129.1 (C-2′ ′); 129.0 (C-2 and C-6); 128.5 (C-3 and C-5); 125.6 (C-3′ ′); 122.0 (C-8′); 120.7 (C-8);
118.0 (C-3′); 117.8 (C-3′); 115.6 (C-1′); 103.3 (C-5′); 69.0 (C-1′ ′); 25.8 (C-11′); 21.8 (C-7′); 17.9 (C-10′); 17.8
(C-4′ ′). MS: M + H ion m/z 363.4702 (C24H26O3: 362.4614).
(2E)-1-[4-(Prenyloxy)-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (6). Yellow solid.
Yield: 79.0%, melting point: 106–108 ◦C. IR (KBr, cm−1): 2959, 1631, 1519, 1374, 1211, 1147, and 990.
1H-NMR (400 MHz, CDCl3): δ 13.37 (s, 1H, 2′-OH), 7.87 (d, J = 15.5 Hz, 1H, H-8); 7.77 (d, J = 9.1 Hz,
1H, H-6′); 7.65 (m, 2H, H-2 and H-6); 7.60 (d, J = 15.4 Hz, 1H, H-7); 7.42 (m, 3H, H-3, H-4 and
H-5); 6.49 (d, J = 9.0 Hz, 1H, H-5′); 5.48 (m, 1H, H-2′ ′); 5.25 (m, 1H, H-8′); 4,62 (d, J = 6.6 Hz, 2H,
H-1′ ′); 3.39 (d, J = 7.2 Hz, 1H, H-7′); 1.80 (s, 6H, H-4′ ′ and H-10′); 1.75 (s, 3H, H-5′ ′); 1.68 (s, 3H,
H-11′). 13C-NMR (100 MHz, CDCl3): δ 192.1 (C-9); 163.2 (C-2′); 162.8 (C-4′); 144.0 (C-7); 138.1 (C-3′ ′);
134.9 (C-1); 131.7 (C-6′); 130.5 (C-9′); 129.1 (C-4); 129.0 (C-2 and C-6); 128,5 (C-3 and C-5); 122.1 (C-8′);
120.7 (C-8); 119.5 (C-2′ ′) 117.9 (C-3′); 114.5 (C-1′); 103.3 (C-5′); 65.3 (C-1′ ′); 25.8 (C-4′ ′); 25.7 (C-11′);
21.8 (C-7′); 18.3 (C-5′ ′); 17.8 (C-10′). MS: M + H ion m/z 377.4972 (C25H28O3: 376.4880).
(2E)-1-[4-(Geranyloxy)-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (7). Yellow
solid. Yield: 73.0%, melting point: 78–80 ◦C. IR (KBr, cm−1): 2940, 2865, 1631, 1530, 1512, 1338, 1241,
1129, 817. 1H-NMR (400 MHz, CDCl3): δ 13.37 (s, 1H, 2′-OH), 7,87 (d, J = 15.5 Hz, 1H, H-8); 7.77 (d,
J = 9.1 Hz, 1H, H-6′); 7.65 (m, 2H, H-2 and H-6); 7.60 (d, J = 15.4 Hz, 1H, H-7); 7.42 (m, 3H, H-3, H-4 and
H-5); 6.49 (d, J = 9.0 Hz, 1H, H-5′); 5.48 (m, 1H, H-2′ ′); 5.25 (m, 1H, H-8′); 5.08 (m, 1H, H-6′ ′); 4.65 (d,
J = 6.4 Hz,2H, H-1′ ′); 3.39 (d, J = 7.2 Hz, 1H, H-7′); 2.10 (m, 4H, H-4′ ′ and H-5′ ′); 1.80 (s, 3H, H-10′); 1.75
(s, 3H, H-9′ ′); 1.68 (s, 3H, H-8′ ′); 1.61 (s, 3H, H-11′). 13C-NMR (100 MHz, CDCl3): δ 191.1 (C-9); 163.1
(C-2′); 162.8 (C-4′); 144.0 (C-7); 141.3 (C-3′ ′); 134.9 (C-1); 131.9 (C-6′); 131.7 (C-7′ ′); 130.5 (C-9′); 129.1
(C-4); 129.0 (C-2 and C-6); 128.5 (C-3 and C-5); 123.7 (C-8′); 120.7 (C-8); 119.3 (C-2′ ′); 117.8 (C-3′); 114.4
(C-1′); 103.3 (C-5′); 65.4 (C-1′ ′); 39.5 (C-4′ ′); 26.3 (C-5′ ′); 25.8 (C-11′); 25.7 (C-8′ ′); 21.8 (C-7′); 17.9 (C-10′);
17.7 (C-10′ ′); 16.7 (C-9′ ′). MS: M + H ion m/z 445.6261 (C30H36O3: 444.6051).
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(2E)-1-[4-(Farnesyloxy)-2-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-3-phenylprop-2-en-1-one (8). Yellow
solid. Yield: 70.0%, melting point: 62–64 ◦C. IR (KBr, cm−1): 2955, 1632, 1541, 1374, 1203, 1140, 978.
1H-NMR (400 MHz, CDCl3): δ 13.37 (s, 1H, 2′-OH), 7.87 (d, J = 15.5 Hz, 1H, H-8); 7.77 (d, J = 9.1 Hz,
1H, H-6′); 7.65 (m, 2H, H-2 and H-6); 7.60 (d, J = 15.4 Hz, 1H, H-7); 7.42 (m, 3H, H-3, H-4 and H-5);
6.49 (d, J = 9.0 Hz, 1H, H-5′); 5.48 (m, 1H, H-2′ ′); 5.25 (m, 1H, H-8′); 5.08 (m, 2H, H-6′ ′ and H-10′ ′);
4.65 (d, J = 6.6 Hz, 2H, H-1′ ′); 3.39 (d, J = 7.2 Hz, 1H, H-7′); 2.09 (m, 4H, H-4′ ′, H-5′ ′, H-8′ ′ and H-9′ ′);
1.80 (s, 6H, H-10′ and H-13′ ′); 1.75 (s, 3H, H-11′); 1.67 (s, 6H, H-14′ ′ and H-15′ ′). 13C-NMR (100 MHz,
CDCl3): δ 192.1 (C-9); 163.2 (C-2′); 162.9 (C-4′); 144.0 (C-7); 141.3 (C-3′ ′); 135.3 (C-7′ ′); 134.9 (C-1);
131.5 (C-9′ and C-11′ ′); 131,3 (C-6′); 130.5 (C-4); 129.0 (C-2 and C-6); 128.5 (C-3 and C-5); 124.3 (C-6′ ′);
123.6 (C-10′ ′); 122.1 (C-8); 120.7 (C-8); 119.3 (C-2′ ′) 117.9 (C-3′); 114.5 (C-1′); 103.3 (C-5′); 65.4 (C-1′ ′);
39.7 (C-4′ ′); 39.5 (C-8′ ′); 26.7 (C-9′ ′); 26.2 (C-5′ ′); 25.8 (C-12′ ′); 25.7 (C-11′); 21.8 (C-7′); 17.9 (C-10′);
17.7 (C-15′ ′); 16.7 (C-14′ ′); 16.0 (C-13′). MS: M + H ion m/z 513.7351 (C35H44O3: 512.7220).
3.5. Oomycete Strain
Pure strains of S. parasitica and S. australis were received from the Cell Biology Laboratory, Faculty
of medicine, Universidad de Valparaíso, placed on potato dextrose agar (PDA) slants, and stored at
4 ◦C. This pure strain was isolated from Salmo salar carp eggs [33].
3.6. Minimum Inhibitory Concentration Evaluation
The method used in this study for anti-oomycete activity assay was performed according to
methods previously reported [34]. The compounds 1–8 were tested at 200.0, 150.0, 100.0, 50.0, 25.0,
12.5, 6.3, and 3.1 µg/L to find a preliminary minimum inhibitory concentration (MIC) interval.
The MIC values were recorded visually on the basis of mycelia growth. All the independent
experiments were conducted three times with quadruplicates at each test concentration. Ethanol
solution 1% in water was the negative control and bronopol, clotrimazole, and itraconazole
were the positive controls.
3.7. Spores Germination Inhibition Assay
The spore germination assay against Saprolegnia strains was performed according to the agar
dilution method [35]. The minimum oomyceticidal concentration (MOC) and detailed protocols for
the biological assays was defined previously [34].
3.8. Mycelial Growth Inhibition Assay
Inhibition of mycelial growth was assayed using the method described by Hu [29] with small
modifications. Oomycete growth was measured as the colony diameter, and toxicity of the compounds
1–8 against Saprolegnia strains was measured in terms of the percentage of mycelia inhibition by
a formula described in detail elsewhere [34].
3.9. Statistical Analysis
The statistical data of recovery rates were performed by comparison within isolates and between
culturing media following a standard method [20].
4. Conclusions
In the current study, we demonstrated that the novel oxyalkylated analogues of isocordoin
(2–8) showed higher inhibitory effect, but isocordoin 1 and chalcone with a geranyl group, such
as 7, showed very weak activity, when compared with bronopol, clotrimazole, and itraconazole.
Derricin (2) and compound 3 are the main compounds responsible for the observed biological activity
against Saprolegnia strains and are potential candidates for drug development based on their effective
anti-oomycete activities.
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